Versant Venture Management, LLC / ADVMCHF
Versant Venture Management, LLC’s Adverum Biotechnologies Inc Position
Does Versant Venture Management, LLC own Adverum Biotechnologies Inc (ADVMCHF)? Not currently — the last reported position was 506.8K shares worth $2M in Q3 2025; the fund’s latest 13F (Q1 2026) no longer reports it.
Position Value
$2M
Q3 2025
Shares
506.8K
% of Portfolio
+1.08%
Quarters Held
23
position exited
Position History ADVMCHF
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q3 2025 | 506.8K | $2M | +1.08% |
| Q2 2025 | 506.8K | $1M | +1.33% |
| Q1 2025 | 506.8K | $2M | +3.68% |
| Q4 2024 | 506.8K | $2M | +2.73% |
| Q3 2024 | 506.8K | $4M | +5.60% |
| Q2 2024 | 506.8K | $3M | +4.50% |
| Q1 2024 | 506.8K | $7M | +6.95% |
| Q4 2023 | 5.07M | $4M | +0.98% |
| Q3 2023 | 5.07M | $8M | +4.04% |
| Q2 2023 | 5.07M | $8M | +9.56% |
| Q1 2023 | 5.07M | $4M | +7.58% |
| Q4 2022 | 5.07M | $3M | +6.08% |
| Q3 2022 | 5.07M | $5M | +8.21% |
| Q2 2022 | 5.07M | $6M | +9.32% |
| Q1 2022 | 5.07M | $7M | +6.63% |
| Q4 2021 | 5.07M | $9M | +4.77% |
| Q3 2021 | 5.07M | $11M | +4.55% |
| Q2 2021 | 5.07M | $18M | +5.88% |
| Q1 2021 | 5.07M | $50M | +9.74% |
| Q4 2020 | 5.00M | $54M | +5.63% |
| Q3 2020 | 7.00M | $72M | +13.20% |
| Q2 2020 | 7.00M | $146.2B | +21.01% |
| Q1 2020 | 7.07M | $69.1B | +18.94% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Versant Venture Management, LLC’s full portfolio or all institutional holders of ADVMCHF.